V18M (p.Val18Met) variant of PRKCB (Protein kinase C beta type)
V18M (p.Val18Met) in PRKCB (Protein kinase C beta type) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.68 / 1. The record also includes population frequency data and structural context.
V18M (p.Val18Met) variant details
- p.Val18Met
- NCI-TCGA Cosmic COSV5776
- cosmic curated COSV57763
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.684
- CADD 22.80
- PolyPhen-2 0.01
- SIFT 0.29
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available